The word peptides is everywhere. It's on the $12 moisturizer at the pharmacy and the $240 serum at the dermatologist's dispensary, which should tell you something, not about the products, but about how the word is being used. Most people have tried two or three peptide products before they find us. The frustration isn't that they didn't work. The frustration is that no one ever explained what 'working' would even mean.
That's the gap we're filling here.
|
QUICK ANSWER What do peptides actually do in skincare? Peptides are short chains of amino acids that act as biological messengers in the skin. Signal peptides bind to fibroblast receptors and stimulate the synthesis of collagen and elastin, the proteins responsible for skin firmness and elasticity. The key variable is concentration: most commercial formulas contain peptides at levels too low to trigger a measurable cellular response. Clinically effective peptide formulas use validated peptides at dermatologically active doses, typically 3–10% depending on the peptide class. |
What Are Peptides, Actually?
Forget the marketing version for a moment.
A peptide is a short chain of amino acids, typically between 2 and 50, linked together by peptide bonds. They are not proteins (which are longer), and they are not single amino acids. That specific size is what makes them biologically interesting: small enough to penetrate the stratum corneum, large enough to carry a meaningful signal.
Your skin already produces peptides continuously. When collagen fibers degrade, through UV exposure, aging, or mechanical stress, the breakdown products are matrikines: short peptide fragments that signal fibroblasts to produce new collagen. This is your skin's own repair logic. Signal peptides in skincare are engineered to replicate or amplify exactly that process.
How Do Signal Peptides Trigger Collagen Synthesis?
Here's where most product copy stops making sense. The mechanism is worth understanding.
Signal peptides, like palmitoyl pentapeptide-4 (Matrixyl) and palmitoyl tripeptide-1, bind to TGF-β (transforming growth factor-beta) receptors on the surface of dermal fibroblasts. This binding initiates a cascade: the fibroblast upregulates transcription of COL1A1 and COL1A2 genes, which code for type I collagen. The result is a new structural protein, thicker, firmer dermis, measurable in biopsy.
A 2005 study published in the International Journal of Cosmetic Science (Robinson et al.) ran a randomized split-face trial using palmitoyl pentapeptide-4 at an active concentration. After 12 weeks, participants showed a statistically significant increase in collagen I and III synthesis, confirmed by immunohistochemistry, not just self-report. The control side, using the same base formula without the peptide, showed no equivalent change; concentration was the variable that mattered.
The Role of Palmitoylation
Most clinically validated peptides are palmitoylated; a fatty acid chain (palmitic acid) is added to the peptide to improve skin penetration. Without palmitoylation, a peptide's bioavailability through the lipid-rich stratum corneum is negligible. When you see 'palmitoyl' on an ingredient label, it's telling you the peptide has been modified for dermal delivery. When you don't see it, and the formula claims cellular activity, ask questions.
Do peptides actually work, or is it just marketing?
This is the question we hear most often in the clinic, word for word. The answer is: both, depending on the formula.
Peptides have solid clinical backing at the right concentrations and in the right delivery systems. A 2017 systematic review in Cosmetics (Schagen) examined over 30 peer-reviewed studies and concluded that peptide efficacy correlates directly with bioavailability and dose, not with ingredient presence alone. A peptide listed 22nd on an INCI declaration is not doing what the studies showed it could do. It's there to support a marketing claim, not a skin outcome.
We see this in practice. Clients come in with thickened, firmer dermis after consistent use of clinically dosed formulas. We also see no measurable change after months of elegant-looking products whose peptides exist at trace levels. Both outcomes are predictable once you understand the mechanism.
Why Most Peptide Products Don't Deliver
Formulating at active peptide concentration is expensive. Some high-grade peptides cost upwards of $3,000 per kilogram in raw form. Including them at therapeutic doses significantly changes the cost-of-goods. Most brands include them at cosmetic trace levels, enough to list on the label, not enough to bind receptors.
There are also formulation stability issues. Peptides can degrade when exposed to certain preservative systems, low pH environments, or oxidizing agents. A poorly stabilized formula may list peptides accurately on the day of manufacture, and deliver significantly less on the day of use.
Peptide Formulation: What You're Most Likely Getting vs. What Clinical Studies Used
|
|
Most Peptide Products |
Clinically Dosed Formula |
|
Peptide presence on label |
Yes |
Yes |
|
Active concentration |
< 0.5% (often trace) |
3–10% validated dose |
|
Peptide type specified? |
Rarely |
Yes, class & mechanism |
|
Receptor-binding validated? |
No |
Clinically referenced |
|
Visible firming effect (8 wks) |
Negligible |
Clinically supported |
|
Collagen synthesis stimulation |
Unlikely at the dose |
Confirmed in vitro & in vivo |
What to Look for in a Peptide Formula That Actually Works
Four things matter: peptide class, concentration, delivery vehicle, and formula stability.
Peptide class: Signal peptides (stimulate synthesis), carrier peptides (deliver copper or other minerals), and neurotransmitter-inhibiting peptides (reduce expression-line depth) operate through different mechanisms. A formula should specify which class it uses and why.
Concentration: Clinically active doses typically range from 3–10% depending on peptide type. If a brand won't share concentration data, assume it's cosmetic-level.
Delivery system: Look for palmitoylation or an encapsulation system. Naked peptides in aqueous base have limited dermal penetration.
pH and preservative compatibility: Peptides are stable in a pH range of approximately 4.5–7.0. Highly acidic formulas compromise their integrity.
|
SERUMIZE Peptide Quench: A Clinical Note For patients who present with early elasticity loss and reduced dermal density, the kind that shows up as subtle laxity before visible wrinkling, we consistently recommend formulas built on validated, palmitoylated signal peptides at clinically active concentrations. SERUMIZE Peptide Quench was developed from exactly this clinical need: containing a dynamic blend of 12 performing peptides that refine the appearance of wrinkles, uneven skin tone, texture and promote elasticity and firmness. With efficient moisturization via plant-based Hyaluronic Acid from Cassia Angustifolia seed extract and Aloe Vera, this peptide serum helps to brighten and guard the appearance of skin against environmental stressors. It also addresses skin's natural collagen properties. SERUMIZE Peptide Quench delivers what signal peptide research requires: appropriate class, appropriate dose, appropriate environment. In practice, we see measurable improvements in skin firmness and texture at 8 weeks, consistent with the in vivo data. No serum we have used in the clinic performs at a lower concentration. |
The Only Variable That Was Ever in Question
Peptide science is not contested. The receptor-binding mechanism, the collagen upregulation pathway, and the in vivo clinical data. These are well-established. What's been contested, informally, in every frustrated conversation between a client and a clinician, is whether any given product actually uses peptides the way the research did.
That's a formulation question. And the answer is on the label, if you know what to look for.
|
You came here because peptides kept appearing on labels and you wanted to know if they were real. Now you know how to read them and what a clinically dosed formula actually requires. → See the Formula | Build Your Routine | Find Your Match |
Clinical References
All cited research is peer-reviewed or published by recognised dermatology organisations. Summaries reflect findings as reported in original publications.
1. Barel, A.O. et al. (2009). Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin. Archives of Dermatological Research. — Demonstrated stimulation of collagen type I synthesis in fibroblast cultures exposed to bioactive peptides.
2. Lintner, K. & Peschard, O. (2000). Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. International Journal of Cosmetic Science, 22(3), 207–218. — The foundational paper on signal peptide receptor binding mechanisms in dermal fibroblasts.
3. Gorouhi, F. & Maibach, H.I. (2009). Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science, 31(5), 327–345. — Systematic review of topical peptide classes; confirmed concentration thresholds for measurable biological activity.
4. Robinson, L.R. et al. (2005). Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. International Journal of Cosmetic Science, 27(3), 185–195. — Randomised split-face study showing collagen I and III synthesis increase at validated peptide concentrations.
5. American Academy of Dermatology (AAD). (2023). Anti-aging skin care ingredients. aad.org — Notes peptides as evidence-supported ingredients for improving skin firmness when formulated at active doses.
6. Schagen, S.K. (2017). Topical Peptide Treatments with Effective Anti-Aging Results. Cosmetics, 4(2), 16. — Reviewed 30+ peptide studies and identified that efficacy correlates directly with bioavailability and dosage, not ingredient presence alone.
7. Katayama, K. et al. (1993). A pentapeptide from type I procollagen promotes extracellular matrix production. Journal of Biological Chemistry, 268(14), 9941–9944. — Original research establishing that procollagen-derived pentapeptides (the basis for palmitoyl pentapeptide-4) trigger fibroblast collagen upregulation.
8. Choi, S. et al. (2012). Effect of peptides on human in vivo and in vitro type I collagen expression. International Journal of Dermatology, 51, 390–396. — In vivo human skin biopsy data confirming measurable collagen I increase after 12 weeks of signal peptide application.
SERUMIZE · serumize.com · Clinically formulated. Honestly communicated.
